UFP Technologies : Submissions of Matters to a Vote of Security Holders (Form 8-K)
June 14, 2021 at 04:18 pm EDT
Share
Submissions of Matters to a Vote of Security Holders.
On June 9, 2021, UFP Technologies, Inc. (the 'Company') held its Annual Meeting of Stockholders (the 'Meeting'). As of the close of business on April 12, 2021, the record date for the Meeting, there were 7,524,479 shares of the Company's common stock outstanding, with each share entitled to one vote. During the Meeting, the Company's stockholders voted on the matters set forth below.
Proposal 1
The five director nominees named in our proxy statement were elected, each for a one-year term as set forth in the Company's proxy statement dated April 27, 2021. The following table sets forth the vote of the stockholders at the Meeting with respect to the election of directors:
Nominee
For
Against
Abstain
Broker Non-Votes
R. Jeffrey Bailly
5,709,700
0
347,528
811,401
Marc Kozin
5,391,450
0
665,778
811,401
Robert W. Pierce, Jr.
5,747,812
0
309,416
811,401
Daniel C. Croteau
5,678,183
0
379,045
811,401
Cynthia L. Feldmann
5,822,906
0
234,322
811,401
Proposal 2
The Company's stockholders voted upon and approved the compensation paid to the Company's named executive officers based upon the following votes:
For
Against
Abstain
Broker Non-Votes
5,525,869
526,224
5,135
811,401
Proposal 3
The Company's stockholders voted upon and approved the amendment and restatement of the Company's 2003 Equity Incentive Plan based upon the following votes:
For
Against
Abstain
Broker Non-Votes
5,624,326
431,744
1,158
811,401
Proposal 4
The Company's stockholders voted upon and approved the ratification of the appointment of Grant Thornton LLP to serve as the Company's independent registered public accounting firm for 2021 based upon the following votes:
For
Against
Abstain
Broker Non-Votes
6,863,813
4,763
53
811,401
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1
Amended and Restated 2003 Incentive Plan (incorporated by reference to Appendix A to the Company's Proxy Statement filed on Schedule 14A, filed with the SEC on May 5, 2021)
Attachments
Original document
Permalink
Disclaimer
UFP Technologies Inc. published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 20:17:01 UTC.
UFP Technologies, Inc. is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other engineered custom products. The Companyâs single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, surfaces and support, wound care, wearables, orthopedic soft goods, and orthopedic implants. The Company is diversified by also providing engineered products and components to customers in the automotive, aerospace and defense, and industrial/other markets. Typical applications of its products include military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It also engineersâ components for automotive use, such as interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials.